AHA, others call for comprehensive strategy to address critical drug shortages

Joint letter to the leadership of the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee on the shortages of critical pharmaceuticals.

Related Resources

Letter
Public
AHA expresses disappointment that the Agency for Healthcare Research and Quality is shutting down the National Guidelines Clearinghouse.
Letter
Public
AHA comments on the Department of Health and Human Services’ Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.
Advisory
Member
On June 12, the Centers for Medicare…
Bibliography/Link Page
SAMHSA's The Dialogue produced
Case Studies
Members in Action: Improve Quality and Patient Outcomes<
Letter
Public
AHA comments on the Centers for Medicare & Medicaid Services’ hospital inpatient prospective payment system proposed rule for fiscal year 2019.